Miguel A Rodriguez-Weber
Overview
Explore the profile of Miguel A Rodriguez-Weber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diez-Domingo J, Saez-Llorens X, Rodriguez-Weber M, Epalza C, Chatterjee A, Chiu C, et al.
J Infect Dis
. 2022 Dec;
227(11):1293-1302.
PMID: 36484484
Background: Safe and effective respiratory syncytial virus (RSV) vaccines remain elusive. This was a phase I/II trial (NCT02927873) of ChAd155-RSV, an investigational chimpanzee adenovirus-RSV vaccine expressing 3 proteins (fusion, nucleoprotein,...
2.
Lopez-Corella E, Ibarra-Gonzalez I, Fernandez-Lainez C, Rodriguez-Weber M, Guillen-Lopez S, Belmont-Martinez L, et al.
Neuropathology
. 2017 Aug;
37(6):586-590.
PMID: 28815739
Ornithine transcarbamylase deficiency (OTCD) is an X-linked urea cycle defect associated with severe and usually fatal hyperammonemia. This study describes a patient with early onset lethal OTCD due to a...
3.
Jain V, Domachowske J, Wang L, Ofori-Anyinam O, Rodriguez-Weber M, Leonardi M, et al.
J Pediatric Infect Dis Soc
. 2017 Jan;
6(1):9-19.
PMID: 28062552
Background.: Children under 3 years of age may benefit from a double-dose of inactivated quadrivalent influenza vaccine (IIV4) instead of the standard-dose. Methods.: We compared the only United States-licensed standard-dose...